glp-1 shortage canada news today As interest in medication grows, scammers are tricking consumers with fake alternatives. Here's how to spot them. http://www.wtae.com/article/weight-loss-scam-warning-fueled-by-glp-1 -hype-ai-deepfakes/69917014 GLP-1 Market Size, Share |

Sargeant JA, Brady EM, Zaccardi F et al (2020) Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials

These could be especially helpful during the menopausal transition, when the diagnosis of these conditions increases

Fidgeting less, walking less, standing less

In particular, changes in alcohol and nicotine use (both directly affecting sedation and recovery) may be more common than expected but not always captured in routine documentation

they often take a few hours to kick in

In November 2025, the drugmaker Novo Nordisk announced that two large and much anticipated studies failed to find any benefit for its GLP-1 medicine in patients with early stage Alzheimers disease